Xinxin Zhu

机构：Ministry of Education of the People's Republic of China, Harbin Engineering University, Harbin Medical University, Huazhong Agricultural University, Shanghai CASB Biotechnology (China), Affiliated Hospital of Taishan Medical University, Second Affiliated Hospital of Harbin Medical University, Taian City Central Hospital · ORCID：0000-0002-7086-1071

发表论文 26 篇 · 总被引 935 次 · h-index 14

代表论文

• Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer (2017 · Oncotarget · 被引 310)
• MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction (2023 · Redox Biology · 被引 117)
• CAR-T cell therapy in ovarian cancer: from the bench to the bedside (2017 · Oncotarget · 被引 77)
• PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker (2016 · SpringerPlus · 被引 69)
• Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer (2017 · Journal of Gynecologic Oncology · 被引 61)
• MicroRNA Dysregulation and Steroid Hormone Receptor Expression in Uterine Tissues of Rats with Endometriosis during the Implantation Window (2018 · Chinese Medical Journal · 被引 34)